.webp)
fh tirzepatide Compounded (GLP-1/GIP) Tirzepatide Weight Loss Injections •
Description
Pratley, MD, and other researchers will share new data on the renal and cardiovascular benefits of GLP-1 receptor agonists.
References: ADA Scientific Sessions 2026 (VESPER-3)
GLP-1 agonists address lipids, inflammation, and cardiovascular risk simultaneously through multiple mechanisms
Considering a weight loss injection such as Ozempic or Wegovy
In addition, studies in which weight loss was greater during treatment than in the control group and studies in which lifestyle interventions were continued observed significant weight gain after drug discontinuation
